Cash shortage offers only ‘limited window’ to sell Helius, administrator tells creditors by Steve Jones March 18, 2026March 18, 2026 Creditors of Helius Therapeutics will meet for the first time on Monday as administrators of the […]
Australian exports to Germany triple as imports top 200 tonnes by Adam Sheldon March 18, 2026March 18, 2026
High THC ‘doesn’t mean a better therapeutic effect’, genetic expert tells prescribers by Adam Sheldon March 17, 2026March 18, 2026
News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026June 8, 2026
‘Lawful practice’ not enough to avoid regulatory action, warns former AHPRA advisor by Adam Sheldon March 17, 2026March 17, 2026
Former Cannim research lead takes senior role at Medigrowth by Steve Jones March 16, 2026March 19, 2026
Head of Beacon Medical set to join Pharmacrop as commercial GM by Steve Jones March 12, 2026March 12, 2026
Rec-style branding risks undermining the industry, warns Bioxyne CEO by Adam Sheldon March 12, 2026March 12, 2026
Campaigners on cusp of major victory as NSW prepares for driving reform by Steve Jones March 11, 2026March 11, 2026
